George Fuad Atweh MD
Professor, Internal Medicine, University of Cincinnati College of Medicine
Join to View Full Profile
1201 Camino de Salud NEAlbuquerque, NM 87102
Phone+1 505-272-4946
Fax+1 505-272-8060
Dr. Atweh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 1980 - 1983
American University of Beirut Faculty of MedicineClass of 1978
Certifications & Licensure
NM State Medical License 2017 - 2027
VT State Medical License 2014 - 2018
FL State Medical License 2014 - 2016
OH State Medical License 2009 - 2015
NY State Medical License 1990 - 2009
MI State Medical License 1985 - 1992
CT State Medical License 1983 - 1985
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2001
- Top MD Consumers Checkbook
Clinical Trials
- Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers Start of enrollment: 1997 Sep 01
Publications & Presentations
PubMed
- EBER-Negative, Double-Hit High-Grade B-Cell Lymphoma Responding to Methotrexate Discontinuation.Nhi Nai, Brittany B Coffman, Kimberly Reiter, George Atweh, Vishal Vashistha
Federal Practitioner. 2024-05-01 - Benchmarks for Academic Oncology FacultyLowell B. Anthony, George F. Atweh, Ravi Bhatia, Lisa A. Carey, Jenny C. Chang
JCO Oncology Practice. 2021-03-01 - 3 citationsStathmin 1 deficiency induces erythro-megakaryocytic defects leading to macrocytic anemia and thrombocythemia in Stathmin 1 knock out mice.Charmaine A. Ramlogan-Steel, Jason C. Steel, Hassana Fathallah, Camelia Iancu-Rubin, George F. Atweh
Blood Cells, Molecules & Diseases. 2021-03-01
Grant Support
- Pulse Arginine Butyrate With Standard Hydroxyurea Therapy In Sickle CellNational Center For Research Resources2006–2007
- Reversal Of Epigenetic Silencing Of The G-Globin GeneNational Heart, Lung, And Blood Institute2003–2006
- Induction Of Fetal Hemoglobin With Arginine ButyrateNational Heart, Lung, And Blood Institute1998–2002
- In Vitro Models Of Sickle Cell Gene TherapyNational Heart, Lung, And Blood Institute1998–2002
- Clinical Trial Of IV Butyrate In Fetal Hemoglobin Beta Globin DisordersNational Center For Research Resources1998–2002
- Retroviral Mediated Globin Gene TherapyNational Heart, Lung, And Blood Institute1997–2000
- Study Of Oral Isobutyramide Increasing Fetal Hemoglobin In Beta Globin DisordersNational Center For Research Resources1997
- Study Of Clinical And Molecular Correlations In The S/Beta ThalassemiaNational Center For Research Resources1997
- Clinical Trial Of IV Butyrate--Fetal Hemoglobin Beta Globin DisordersNational Center For Research Resources1996–1997
- Retroviral Mediated Globin Gene TherapyNational Heart, Lung, And Blood Institute1996
- Pharmacologic/Gene Therapy Approaches To Treatment Of Hemoglobin DisordersNational Center For Research Resources1995
- Normal And Aberrant Globin Gene ExpressionNational Heart, Lung, And Blood Institute1994–1995
- Study Of Normal And Aberrant Globin Gene ExpressionNational Heart, Lung, And Blood Institute1992–1993
- Normal And Aberrant Globin Gene ExpressionNational Heart, Lung, And Blood Institute1989–1992
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
